HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Master Thesis

Accompagnement des patient(e)s atteint(e)s de sclérose en plaques à l’officine

Abstract : Multiple sclerosis (MS) is a chronic neurodegenerative disease, inflammatory and demyelinating, affecting the central nervous system. MS is the leading cause of non-traumatic handicap among young adults. The underlying cause of MS is not clear, however, genetic and environmental factors have been identified. We know that the immune system is involved in the mechanisms of demyelination. The disease occurs through varying symptoms depending on the affected regions of the central nervous system, which can negatively influence patient’s physical (impaired balance, muscle spasticity…) and mental abilities (cognitive impairment, anxiety, depression …). While there is no cure for MS, recent studies have considerably broadened the therapeutic arsenal, notably background treatments, a certain number of which are readily available in pharmacies. This thesis is an assessment of the state-of-the-art concerning MS, its symptoms and associated treatments in order to define the scope of possibilities at the officinal level in the hopes of improving care and management of MS patients.
Document type :
Master Thesis
Complete list of metadata

Contributor : Ufr Santé Unicaen Connect in order to contact the contributor
Submitted on : Wednesday, March 23, 2022 - 3:24:42 PM
Last modification on : Saturday, April 9, 2022 - 3:43:43 AM


Files produced by the author(s)


  • HAL Id : dumas-03617591, version 1


Antoine Jegou. Accompagnement des patient(e)s atteint(e)s de sclérose en plaques à l’officine. Sciences pharmaceutiques. 2021. ⟨dumas-03617591⟩



Record views


Files downloads